BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4036990)

  • 21. May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency?
    Pozzi L; Della Valle P; D'Angelo A
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):52-53. PubMed ID: 30672814
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary amyloidosis and myelomatosis associated with excessive fibrinolytic acitivty.
    Millard LG; Rowell NR
    Br J Dermatol; 1976 May; 94(5):569-71. PubMed ID: 1268067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemorrhagic syndrome and isolated alpha 2-antiplasmin deficiency. Apropos of a case].
    Guermazi S; Khelif A; Conrad J; Ennabli S; Dellagi K
    Pathol Biol (Paris); 1997 Jun; 45(6):483-6. PubMed ID: 9309264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report.
    Mohammed BAB
    J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
    Colucci G; Alberio L; Jahns M; Keller P; Steiner S; Rüsges-Wolter I; Lämmle B
    Thromb Haemost; 2009 Dec; 102(6):1285-7. PubMed ID: 19967165
    [No Abstract]   [Full Text] [Related]  

  • 26. Termination of bleeding by a specific, anticatalytic antibody against plasmin.
    Zhao T; Houng A; Reed GL
    J Thromb Haemost; 2019 Sep; 17(9):1461-1469. PubMed ID: 31136076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new life-long hemorrhagic disorder due to excess plasminogen activator.
    Booth NA; Bennett B; Wijngaards G; Grieve JH
    Blood; 1983 Feb; 61(2):267-75. PubMed ID: 6681588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
    Yoshioka A; Kamitsuji H; Takase T; Iida Y; Tsukada S; Mikami S; Fukui H
    Haemostasis; 1982; 11(3):176-84. PubMed ID: 7095605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency.
    Kordich L; Feldman L; Porterie P; Lago O
    Thromb Res; 1985 Dec; 40(5):645-51. PubMed ID: 4089832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
    Kettle P; Mayne EE
    J Clin Pathol; 1985 Apr; 38(4):428-9. PubMed ID: 3988955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase.
    Liebman HA; Carfagno MK; Weitz IC; Berard P; Diiorio JM; Vosburgh E; Simms RW
    Am J Clin Pathol; 1992 Nov; 98(5):534-41. PubMed ID: 1485607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel variant causing α2 antiplasmin deficiency: case report and experience in a UK centre.
    Akay M; Zaidi A; Vaidya S; Sivapalaratnam S; Theodoulou A; Platton S; Hart D; Pasi J; Bowles L
    Br J Haematol; 2019 Oct; 187(2):e42-e44. PubMed ID: 31441040
    [No Abstract]   [Full Text] [Related]  

  • 34. Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.
    Takahashi R; Ono K; Ikeda T; Akagi A; Noto D; Nozaki I; Sakai K; Asakura H; Iwasa K; Yamada M
    Amyloid; 2012 Sep; 19(3):129-32. PubMed ID: 22624582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic fibrinolysis as a cause of clinical bleeding.
    Stump DC; Taylor FB; Nesheim ME; Giles AR; Dzik WH; Bovill EG
    Semin Thromb Hemost; 1990 Jul; 16(3):260-73. PubMed ID: 2237447
    [No Abstract]   [Full Text] [Related]  

  • 36. A single thymine nucleotide deletion responsible for congenital deficiency of plasmin inhibitor.
    Yoshinaga H; Nakahara M; Koyama T; Shibamiya A; Nakazawa F; Miles LA; Hirosawa S; Aoki N
    Thromb Haemost; 2002 Jul; 88(1):144-8. PubMed ID: 12152655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
    Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
    Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A congenital α2-antiplasmin deficiency].
    Igala M; Oukkach B; Khoubila N; Faez S; Benchekroun S
    Ann Biol Clin (Paris); 2013; 71(1):93-5. PubMed ID: 23396430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Congenital deficiency of alpha 2-plasmin inhibitor].
    Aoki N
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):999-1002. PubMed ID: 3270919
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blind spots of the diagnostic hemostasis screen].
    Levi M; Peters M; Briët E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.